LY6K and non-small cell lung carcinoma: Silencing of LY6K reduced the proliferation of CCSCs, which is consistent with previous studies, demonstrating that LY6K downregulation inhibits proliferation through the miR-500a-3p signaling axis in non-small cell lung cancer [28].